¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"neuronal migration abnormality"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® developmental abnormality ÇÑ±Û ¹ß´ÞÀÌ»ó
¼³¸í   
  ¹ß´Þ°úÁ¤, Áï ¼öÅ·κÎÅÍ »çÃá±â³ª ¾î¸¥ÀÌ µÇ¾î ¼º¼÷ÀÌ µÉ ¶§±îÁö »çÀÌ¿¡ ¾î´À ½Ã±â¿¡¼­ »ý±â´Â ÀÌ»óÀÌ´Ù. ±×·¯³ª Á¼Àº Àǹ̷δ ¼öźÎÅÍ Ãâ»ý±îÁöÀÇ ±â°£¿¡ »ý±ä ÀÌ»ó Áï ¼±ÃµÀÌ»óÀ» ÀǹÌÇÑ´Ù. ¼±ÃµÀÌ»ó(congenital abnormality)°ú µ¿ÀǾî.
¿µ¹® chromosome abnormality ÇÑ±Û ¿°»öüÀÌ»ó
¼³¸í   
  ¿°»öüÀÇ ¼ö³ª ±¸Á¶ÀÇ ÀÌ»ó. ÀÌ»óÀÌ »ý±ä ¼¼Æ÷³ª °³Ã¼´Â À¯ÀüÀûÀΠÀÌ»óÀ» ÀÏÀ¸ÄÑ »ç¶÷ÀÇ °æ¿ì, ´Ù¿î ÁõÈıº-ÅͳʠÁõÈıº µûÀ§ÀÇ ¿©·¯ °¡Áö ÇüÅ·Π³ªÅ¸³­´Ù.
¿µ¹® abnormality, anomaly ÇÑ±Û ÀÌ»ó, ºñÁ¤»ó
¼³¸í   
  Á¤»óÀ» ¹þ¾î³­ ¼ºÁú È¤Àº »ç½Ç. anomaly, aberration µîµµ ÀÌ»ó »óŸ¦ ³ªÅ¸³»´Â °ÍÀÌÁö¸¸ abnormality°¡ °¡Àå ³ÐÀº ÀǹÌÀÇ ÀÌ»óÀÌ´Ù. anomaly´Â º¸Åë ¼±ÃµÀû ÀÌ»óÀ» ÀǹÌÇϸç, aberrationÀº ¸Ç ´«À¸·Î º¸ÀÌÁö ¾Ê´Â ÀÌ»óÀ» ÀǹÌÇϴ °æ¿ì°¡ ¸¹´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • piriform neuronal layer
    Á¶·Õ¹Ú¼¼Æ÷Ãþ
  • cellular migration
    ¼¼Æ÷À̵¿
  • migration
    ÀÌÁÖ, À̵¿
  • migration defect
    ÀÌÁÖ°áÇÔ
  • migration inhibition factor
    À̵¿ÀúÁöÀÎÀÚ
  • migration inhibition test
    À̵¿¾ïÁ¦°Ë»ç, À̵¿ÀúÁö°Ë»ç
  • macrophage migration inhibitory factor
    Å«Æ÷½Ä¼¼Æ÷À̵¿ÀúÁöÀÎÀÚ, ´ë½Ä¼¼Æ÷À̵¿ÀúÁöÀÎÀÚ
  • net migration rate
    ¼øÀÌÁÖÀ²
  • abnormality
    ÀÌ»ó, ºñÁ¤»ó
  • chromosomal abnormality
    ¿°»öüÀÌ»ó
  • developmental abnormality
    ¹ß´ÞÀÌ»ó
  • growth abnormality
    ¼ºÀåÀÌ»ó
  • motor abnormality
    ¿îµ¿ÀÌ»ó
  • metabolic abnormality
    ´ë»çÀÌ»ó
  • nailfold capillary abnormality
    ¼ÕÅéÁÖ¸§¸ð¼¼Ç÷°üÀÌ»ó
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • migration
    À̵¿, ÀÌÁÖ
  • abnormality
    ÀÌ»ó, ºñÁ¤»ó
  • chromosomal abnormality
    ¿°»öüÀÌ»ó
  • motor abnormality
    ¿îµ¿Àå¾Ö
  • positional abnormality
    À§Ä¡ÀÌ»ó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neuronal storage disease
    ½Å°æ¼¼Æ÷ÀúÀ庴
  • piriform neuronal layer
    Á¶·Õ¹Ú¼¼Æ÷Ãþ
  • abnormality
    ÀÌ»ó, ºñÁ¤»ó
  • chromosome abnormality
    ¿°»öüÀÌ»ó
  • developmental abnormality
    ¹ß´ÞÀÌ»ó
  • growth abnormality
    ¼ºÀåÀÌ»ó
  • metabolic abnormality
    ´ë»çÀÌ»ó
  • motor abnormality
    ¿îµ¿Àå¾Ö
  • nailfold capillary abnormality
    ¼ÕÅéÁÖ¸§¸ð¼¼Ç÷°üÀÌ»ó
  • positional abnormality
    À§Ä¡ÀÌ»ó
  • protonflow abnormality
    ¾çÀÚÈ帧ÀÌ»ó
  • catadromous migration
    °­·ùÀ̵¿
  • cellular migration
    ¼¼Æ÷À̵¿
  • migration defect
    ÀÌÁÖ°áÇÔ
  • macrophage migration inhibitory factor
    Å«Æ÷½Ä¼¼Æ÷À̵¿ÀúÁöÀÎÀÚ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inhibition test, migration
    À¯ÁÖ¾ïÁ¦½ÃÇè, À¯ÁÖÀúÁö½ÃÇè
  • inhibition(-tory) factor, macrophage migration
    ´ë½Ä¼¼Æ÷ À¯ÁÖÀúÁöÀÎÀÚ
  • abnormality
    ºñÁ¤»ó
  • abnormality by infection
    °¨¿°±âÇü
  • abnormality of cell interaction
    ¼¼Æ÷»óÈ£ÀÛ¿ëÀÌ»ó
  • abnormality of conduction
    ÀüµµÀÌ»ó.
  • abnormality of organ
    ±â°üÀÌ»ó
  • abnormality of tissue
    Á¶Á÷ÀÌ»ó
  • growth abnormality
    ¹ßÀ°ÀÌ»ó.
  • growth abnormality
    ¼ºÀåÀÌ»ó
  • positional abnormality
    À§Ä¡ÀÌ»ó(êÈöÇì¶ßÈ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neuronal heterotopia
    À̼Ҽº ½Å°æ¿ø(ì¶á¶àõ ¡­)
  • neuronal storage disease
    ½Å°æ¼¼Æ÷¼ºÀúÀåÁúȯ(¡­á¬øààõîÍíúòðü´)
  • abnormality
    ºñÁ¤»ó
  • abnormality by infection
    °¨¿°±âÇü
  • abnormality of cell interaction
    ¼¼Æ÷»óÈ£ÀÛ¿ëÀÌ»ó
  • abnormality of conduction
    ÀüµµÀÌ»ó.
  • abnormality of organ
    ±â°üÀÌ»ó
  • abnormality of tissue
    Á¶Á÷ÀÌ»ó
  • autosomal abnormality
    »ó¿°»öüÀÌ»ó(¡­æøßäô÷ì¶ßÈ).
  • behavioral abnormality =b. disorder
    ÇൿÀÌ»ó(ú¼ÔÑì¶ßÈ)=ÇൿÀå¾Ö
  • catadromous migration
    °­·ùÀ̵¿(¡­ì¹ÔÑ).
  • cell migration disorder
  • chromosomal abnormality
    ¿°»öüÀÌ»ó
  • chromosome abnormality
    ¿°»öü ÀÌ»ó(¡­ì¶ßÈ).
  • developmental abnormality
    ¹ßÀ°ÀÌ»ó(Û¡ëÀì¶ßÈ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Migration defect
    ÀÌÁÖ°áÇÔ
    [¿¾ ¿ë¾î] ÀÌÁÖ°áÇÔ
  • Abnormality by infection
    °¨¿°±âÇü
    [¿¾ ¿ë¾î] °¨¿°ºñÁ¤»ó
  • Abnormality of organ
    ±â°üÀÌ»ó
    [¿¾ ¿ë¾î] ±â°üÀÌ»ó
  • Abnormality
    ºñÁ¤»ó
    [¿¾ ¿ë¾î] ºñÁ¤»ó
  • Growth abnormality
    ¼ºÀåÀÌ»ó
    [¿¾ ¿ë¾î] ¼ºÀåÀÌ»ó
  • Abnormality of tissue
    Á¶Á÷ÀÌ»ó
    [¿¾ ¿ë¾î] Á¶Á÷ÀÌ»ó
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • extraintestinal migration
    Àå¿ÜÀÌÇà (íóèâì¹ú¼)
  • lung migration
    ÆóÀÌÇà
  • somatic migration
    Á¶Á÷ÀÌÇà
  • tracheal migration
    ±â°üÀÌÇà
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • branch migration
    °¡ÁöÀ̵¿(ì¹ÔÑ)
  • bridge migration
    ±³·®À̵¿(ÎéÕÙì¹ÔÑ)
  • eddy migration
    ¿ÍÀ̵¿(è¾ì¹ÔÑ)
  • ionic migration
    À̿ À̵¿(ì¹ÔÑ)
  • migration
    À̵¿(ì¹ÔÑ)
  • migration enhancement factor
    À̵¿Ç×Áø ÀÎÀÚ(ì¹ÔÑùñòäì×í­)
  • migration inhibition factor
    À̵¿ÀúÇØ ÀÎÀÚ(ì¹ÔÑîÁúªì×í­)
  • relative migration distance
    »ó´ë À̵¿°Å¸®(ßÓÓßì¹ÔÑËå×î)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • migration
    ÀÌÁÖ, À̵¿, À¯ÁÖ
  • abnormality
    ÀÌ»ó, ÀÌ»ó¼º
  • developmental abnormality
    ¹ßÀ°ÀÌ»ó
  • growth abnormality
    ¹ßÀ°ÀÌ»ó
  • proton flow abnormality
    ¾çÀÚÀ¯µ¿ÀÌ»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MI first meiotic metaphase; maturation index; medical illustrator; medical informatics; medical inspect...
LNP large neuronal polypeptide
NCL neuronal ceroid-lipofuscinosis; nucleolin
SCN1A sodium channel, neuronal alpha-subunit type 1
DMI Defense Mechanism Inventory; Diagnostic Medical Instruments; diaphragmatic myocardial infarction; di...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NMD Neuronal migration disorders
SCIWORA Spinal Cord Injury Without Radiographic Abnormality
WMA Wall motion abnormality
DND Delayed neuronal death
INCL Infantile neuronal ceroid lipofuscinosis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • neuronal cell membrane
    ´º¿ì·± ¼¼Æ÷¸·
  • neuronal heterotopia
    À̼Ҽº ½Å°æ¿ø
  • neuronal representation
    ´º¿ì·± Ç¥Çö
  • neuronal storage disease
    ½Å°æ ÃàÀûÁõ
  • self-exciting neuronal loop
    ÀÚ¹ß ÈïºÐ¼º ½Å°æ ·ç¿ìÇÁ
  • factor macrophage migration inhibition
    ´ë½Ä ¼¼Æ÷ À¯ÁÖ ÀúÁö ÀÎÀÚ
  • lymphocyte migration
    Àӯı¸ À̵¿
  • macrophage migration inhibitory factor
    ´ë½Ä ¼¼Æ÷ À¯ÁÖ ÀúÁö ÀÎÀÚ, °Å½Ä ¼¼Æ÷ À¯ÁÖ ¾ïÁ¦ ÀÎÀÚ
  • migration
    ÀÌÁÖ, À̵¿, À¯ÁÖ, ÀÌÇà, ÀÌÀÔ
    Áõ»ó µîÀÇ ºÎÀ§°¡ ÀÚ¿¬ÀûÀ¸·Î ¸í¹éÇÏ°Ô º¯È­ÇÏ´Â °Í. Ç÷°ü º®À» ÅëÇÑ ¹éÇ÷±¸ÀÇ À̵¿.
  • migration inhibitory factor test
    À¯ÁÖ ÀúÁö ÀÎÀÚ ½ÃÇè
    ƯÀÌ Ç׿ø¿¡ ¹ÝÀÀÇÏ¿© ¸²ÇÁ±¸°¡ MIF¸¦ »ý¼ºÇÏ´Â µ¥ ´ëÇÑ »ýüÀÇ ½ÃÇè¹ýÀ¸·Î ¼¼Æ÷ ¸Å°³ ¸é¿ªÀ» Æò°¡ÇÏ´Â µ¥ »ç¿ëÇÑ´Ù. ÀϺΠ¸é¿ª °áÇÌ Áúº´, Áï DiGeorge ÁõÈıº, Wiskott-Aldrich ÁõÈıº, Hodgkin º´¿¡¼­´Â MIF°¡ »ý¼ºµÇÁö ¾Ê´Â´Ù.
  • migration theory
    À̵¿¼³
  • physiologic migration of the teeth
    »ý¸®Àû Ä¡¾Æ À̵¿
  • abnormality
    ÀÌ»ó¼º, ºñÁ¤»ó, ÀÌ»ó, ±âÇü
    µ¿ÀǾî=abnormity. 1. ºñÁ¤»óÀûÀÎ ¼ºÁúÀ̳ª »ç½Ç.
  • abnormality of cell interaction
    ¼¼Æ÷ »óÈ£ÀÛ¿ë ÀÌ»ó
    ¼¼Æ÷ »çÀÌ¿¡ ÀϾ´Â ÀÛ¿ëÀÌ ºñÁ¤»óÀûÀÎ °Í.
  • abnormality of organ
    ±â°ü ÀÌ»ó
    Æó, ½ÉÀå, °£Àå, ÃéÀå, ½ÅÀå µî°ú °°Àº ±â°üÀÇ Çüųª ¼ö°¡ Á¤»óÀûÀÌÁö ¾ÊÀº »óÅÂ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
abnormality 1. The state or quality of being abnormal.
2. An anomaly, deformity, malformation, impairment, or dysfunction.
(05 Mar 2000)
snowman abnormality A radiographic appearance associated with total anomalous drainage of the pulmonary venous circulation into enlarged right and anomalous left venae cavae, that produces a globular density above the heart; the silhouette suggests the figure 8.
Synonym: snowman abnormality.
(05 Mar 2000)
karyotypic abnormality Abnormality in the number form or structure of chromosomes. Particular abnormalities are associated with particular sub- types of leukaemia.
(27 Sep 1997)
figure-of-8 abnormality A radiographic appearance associated with total anomalous drainage of the pulmonary venous circulation into enlarged right and anomalous left venae cavae, that produces a globular density above the heart; the silhouette suggests the figure 8.
Synonym: snowman abnormality.
(05 Mar 2000)
adrenergic neuronal blocking agent A drug that prevents the release of norepinephrine from sympathetic nerve terminals; it does not inhibit the responses of the adrenergic receptors to circulating epinephrine, norepinephrine, and other adrenergic amines.
(05 Mar 2000)
cell adhesion molecules, neuronal Surface ligands that mediate cell-to-cell adhesion and function in the assembly and interconnection of the vertebrate nervous system. These molecules promote cell adhesion via a homophilic mechanism. These are not to be confused with ncam (neural cell adhesion molecule), now known to be expressed in a variety of tissues and cell types in addition to nervous tissue.
(12 Dec 1998)
primary neuronal degeneration <disease> A progressive, neurodegenerative disease characterised by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.
The cause of nerve cell death is unknown but the cells are recognised by the appearance of unusual helical protein filaments in the nerve cells (neurofibrillary tangles) and by degeneration in cortical regions of brain, especially frontal and temporal lobes.
Alzheimer's disease is the most common cause of dementia.
(22 May 1997)
neuronal <anatomy> Pertaining to a neuron or neurons (= conducting cells of the nervous system).
(18 Nov 1997)
neuronal ceroid-lipofuscinosis A heritable lipidosis with cytoplasmic inclusions staining for ceroid and lipofuscin. Clinically the patient has progressive dementia, retinal degeneration, seizures, and myoclonic jerks. It was formerly thought to be related to tay-sachs disease but the biochemical defect is as yet undetermined. Named according to age of onset: jansky-bielschowsky disease, 2-4 years; batten-spielmeyer-vogt disease, 5-11 years; and kufs disease, adult.
(12 Dec 1998)
neuronal differentiation Acquisition during development of specific biochemical, physiological and morphological properties by nerve cells.
(18 Nov 1997)
neuronal guidance <cell biology> General term for mechanisms that ensure correct projections by nerve cells in developing and regenerating nervous systems. Implies accurate navigation by growth cones, the highly motile tips of growing neuronal processes.
See: growth cone collapse.
(12 Mar 1998)
neuronal hyperplasia Increased numbers of ganglion cells with myenteric plexus hyperplasia and increased acetylcholinesterase activity in nerves of the mucosa and submucosa. Clinically, neuronal hyperplasia mimics Hirschprung's disease. Similar findings are seen in patients with multiple endocrine neoplasia syndrome, type IIB, and in neurofibromatosis.
Synonym: hyperganglionosis, neuronal intestinal dysplasia.
(05 Mar 2000)
neuronal intestinal dysplasia Increased numbers of ganglion cells with myenteric plexus hyperplasia and increased acetylcholinesterase activity in nerves of the mucosa and submucosa. Clinically, neuronal hyperplasia mimics Hirschprung's disease. Similar findings are seen in patients with multiple endocrine neoplasia syndrome, type IIB, and in neurofibromatosis.
Synonym: hyperganglionosis, neuronal intestinal dysplasia.
(05 Mar 2000)
neuronal plasticity Ability of nerve cells to change their properties for example by sprouting new processes, making new synapses or altering the strength of existing synapses.
See: long-term potentiation.
(18 Nov 1997)
neuronal polarity Distribution of specific functions to discrete cellular domains: for example axons and dendrites that have different molecular composition, morphology and ultrastructure and perform different functions.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • migration
    ÀÌÁÖ;(ºÐÀÚ³»ÀÇ)¿øÀÚ À̵¿
  • abnormality
    ºñÁ¤»ó
  • abnormality
    ÀÌ»ó;º¯Ä¢;º´½Å;ºÒ±¸
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á